The influence of cochlear hair cell and spiral ganglia neuron loss on calcium binding protein immunoreactivity (calretinin, parvalbumin and calbindin) in the dorsal and posteroventral cochlear nuclei (DCN and PVCN) in CBA/CaJ (CBA) mice during aging (1–39 months) was determined. Since calcium binding proteins have buffering properties against calcium overload, they may have a protective role during aging. It is shown that the percentage of calretinin- and parvalbumin-immunopositive neurons in the DCN showed a statistically significant positive correlation with inner hair cell loss, outer hair cell loss, and spiral ganglion cell loss. A correlation was also found between aging and the auditory periphery, and calcium binding proteins in the DCN. These findings imply that the pathophysiological state of the auditory periphery may influence the neuronal homeostasis in the dorsal cochlear nucleus.

Keywords:
Hair cells, Spiral ganglia neurons, Parvalbumin, Calretinin, Calbindin quantification, Aging
1.
Baimbridge KG, Celio MR, Rogers JH: Calcium-binding proteins in the nervous system. Trends Neurosci 1992;15:303–308.
2.
Braun K, Scheich H, Schachner M, Heizmann CW: Distribution of parvalbumin, cytochrome oxidase activity and 14C-2 deoxyglucose uptake in the brain of zebra finch. Cell Tissue Res 1985;240:117–127.
3.
Caicedo A, d’Aldin C, Eybalin M, Puel J-L: Temporary sensory deprivation changes calcium-binding proteins levels in the auditory brainstem. J Comp Neurol 1997;378:1–15.
4.
Caicedo A, d’Aldin C, Puel J-L, Eybalin M: Distribution of calcium-binding protein immunoreactivities in the guinea pig auditory brainstem. Anat Embryol 1996;194:465–487.
5.
Cant NB: The cochlear nucleus: Neuronal types and their synaptic organization; in Webster DB, Popper AN, Fay RR (eds): The Mammalian Auditory Pathway: Neuroanatomy. New York, Springer, 1992, pp 66–116.
6.
Carr PA, Yamamoto T, Karmy G, Baimbridge KG, Nagy JI: Ananlysis of parvalbumin and calbindin D28k-immunoreactive neurons in dorsal root ganglia of rat in relation to their cytochrome oxidase and carbonic anhydrase content. Neuroscience 1989;33:363–371.
7.
Conlee JW, Kane ES: Descending projections from the inferior colliculus to the dorsal cochlear nucleus in the cat: An autoradiographic study. Neuroscience 1982;7:161–178.
8.
Edmonds B, Reyes R, Schwaller B, Roberts WM: Calretinin modifies presynaptic signaling in frog saccular hair cells. Nat Neurosci 2000;3:786–790.
9.
Förster CR, Illing RB: Plasticity of the auditory brainstem: Cochleotomy-induced changes of calbindin-D28k expression in the rat. J Comp Neurol 2000;416:173–187.
10.
Gundersen HJ: Stereology of arbitrary particles: A review of unbiased number and size estimators and the presentation of some new ones, in memory of William R. Thompson. J Microsc 1986;143:3–45.
11.
Heizmann CW, Braun K: Changes in Ca2+-binding proteins in human neurodegenerative disorders. Trends Neurosci 1992;15:259–264.
12.
Henry KR, Chole RA: Genotypic differences in behavioral, physiological and anatomical expressions of age-related hearing loss in the laboratory mouse. Audiology 1980;19:369–383.
13.
Idrizbegovic E, Bogdanovic N, Canlon B: Modulating calbindin and parvalbumin immunoreactivity in the cochlear nucleus by moderate noise exposure in mice: A quantitative study on the dorsal and posteroventral cochlear nucleus. Brain Res 1998;800:86–96.
14.
Idrizbegovic E, Bogdanovic N, Canlon B: Sound stimulation increases calcium-binding protein immunoreactivity in the inferior colliculus in mice. Neurosci Lett 1999;259:49–52.
15.
Idrizbegovic E, Canlon B, Bross LS, Willott JF, Bogdanovic N: The total number of neurons and calcium binding protein-positive neurons during aging in the cochlear nucleus of CBA/CaJ mice: A quantitative study. Hear Res 2001, in press.
16.
Kane ES: Synaptic organization in the dorsal cochlear nucleus of the cat: A light and electron microscopic study. J Comp Neurol 1974;155:301–330.
17.
Kawaguchi Y, Katsumaru H, Kosaka T, Heizmann CW, Hama K: Fast spiking cells in rat hippocampus (CA1 region) contain the calcium-binding protein parvalbumin. Brain Res 1987;416:369–374.
18.
Keithley EM, Feldman ML: Hair cell counts in an age-graded series of rat cochleas. Hear Res 1982;8:249–262.
19.
Keithley EM, Ryan AF, Woolf NK: Spiral ganglion cell density in young and old gerbils. Hear Res 1989;38:125–133.
20.
Lambert PR, Schwartz IR: A longitudinal study of changes in the cochlear nucleus in the CBA mouse. Otolaryngol Head Neck Surg 1982;90:787–794.
21.
Li HS, Hultcrantz M: Age-related degeneration of the organ of Corti in two genotypes of mice. ORL J Otorhinolaryngol Relat Spec 1994;56:61–67.
22.
Lorento de Nó R: Anatomy of the eighth nerve. III. General plans of structure of the primary cochlear nuclei. Laryngoscope 1933;43:327–350.
23.
McMullen NT, Smelser BC, DeVenecia RK: A quantitative analysis of parvalbumin neurons in rabbit auditory neocortex. J Comp Neurol 1994;349:493–511.
24.
Melamed SB, Kaltenbach JA, Church MW, Burgio DL, Afman CE: Cisplatin-induced increases in spontaneous neural activity in the dorsal cochlear nucleus and associated outer hair cell loss. Audiology 2000;39:24–29.
25.
Morest DK, Kim J, Bohne BA: Neuronal and transneuronal degeneration of auditory axons in the brainstem after cochlear lesions in the chinchilla: Cochleotopic and non-cochleotopic patterns. Hear Res 1997;103:151–168.
26.
Mugnaini E, Osen KK, Dahl A-L, Friedrich VL, Korte G: Fine structure of granule cells and related interneurons (termed Golgi cells) in the cochlear nuclear complex of cat, rat and mouse. J Neurocytol 1980;9:537–570.
27.
Oertel D, Wu SH, Garb MW, Dizak C: Morphology and physiology of cells in slice preparations of the posteroventral cochlear nucleus of mice. J Comp Neurol 1990;295:136–154.
28.
Osen KK, Mugnaini E: Neuronal circuits in the dorsal cochlear nucleus; in Syka J, Aitkin L (eds): Neuronal Mechanisms of Hearing. New York, Plenum, 1981, pp 119–125.
29.
Shimada A, Ebisu M, Morita T, Takeuchi T, Umemura T: Age-related changes in the cochlea and cochlear nuclei of dogs. J Vet Med Sci 1998;60:41–48.
30.
Spongr VP, Flood DG, Frisina RD, Salvi RJ: Quantitative measures of hair cell loss in CBA and C57BL/6 mice throughout their life spans. J Acoust Soc Am 1997;101:3546–3553.
31.
Wang J, Powers NL, Hofstetter P, Trautwein P, Ding D, Salvi R: Effects of selective inner hair cell loss on auditory nerve fiber threshold tuning and spontaneous and driven discharge rats. Hear Res 1997;107:67–82.
32.
West JM, Slomianka L, Gundersen HJG: Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 1991;231:482–497.
33.
Wickesberg RE, Oertel D: Tonotopic projection from the dorsal to the anteroventral cochlear nucleus of mice. J Comp Neurol 1988;268:389–399.
34.
Willott JF: Aging and the auditory system: Anatomy, physiology, and psychophysics. San Diego, Singular Press, 1991a.
35.
Willott JF, Bross LS: Morphology of the octopus cell area of the cochlear nucleus in young and ageing C57BL/6J and CBA/J mice. J Comp Neurol 1990;300:61–81.
36.
Willott JF, Bross LS, McFadden SL: Morphology of the dorsal cochlear nucleus in C57BL/6J and CBA/J mice across the life span. J Comp Neurol 1992;321:666–678.
37.
Willott JF, Parham K, Hunter KP: Response properties of inferior colliculus neurons in young and very old CBA/J mice. Hear Res 1988;37:1–14.
38.
Willott JF, Parham K, Hunter KP: Comparison of the auditory sensitivity of neurons in the cochlear nucleus and inferior colliculus of young and aging C57BL/6J and CBA/J mice. Hear Res 1991b;53:78–94.
39.
Winsky L, Jacobowitz DM: Effects of unilateral cochlea ablation on the distribution of calretinin mRNA and immunoreactivity in the guinea pig ventral cochlear nucleus. J Comp Neurol 1995;354:564–582.
40.
Zirpel L, Rubel EW: Eighth nerve activity regulates intracellular calcium concentration of avian cochlear nucleus neurons via a metabotropic glutamate receptor. J Neurophysiol 1996;76:4127–4139.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.